Forward Citations = 513

Loading Chart...

6 inventors (with patents filed for the assignee):

Michael Kasinkas (4 out of 9 patents)

Robert J Ziebol (3 out of 44 patents)

Robert A Van Tassel (2 out of 65 patents)

4. Christopher H Porter (2 out of 39 patents)

5. Mark A Rydell (2 out of 78 patents)

6. Curtis A Amplatz (2 out of 5 patents)

5 patents: Sort by Forward Citations

1. 6263236 - Non-occlusive expandable catheter (2001-07-17),

2. 6200307 - Treatment of in-stent restenosis using cytotoxic radiation (2001-03-13),

3. 5964751 - Light delivery system with blood flushing capability (1999-10-12),

4. 5833682 - Light delivery system with blood flushing capability (1998-11-10),

5. 5776174 - Stabilization of vascular lesions by ultraviolet radiation (1998-07-07),

Company Overview

Illumenex Corporation is a leading provider of innovative LED lighting solutions. With a focus on energy efficiency, sustainability, and quality, Illumenex is dedicated to providing cutting-edge lighting technology for commercial and residential applications. Our products are designed to reduce energy consumption, lower maintenance costs, and create a more comfortable and productive environment for our customers.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#75 in Plymouth, MN

#1,421 in Minnesota

#51,620 in US

Plymouth, MN, United States of America

Illumenex Corporation

Forward Citations = 513

6 inventors:

Michael Kasinkas (4 out of 9 patents)

Robert J Ziebol (3 out of 44 patents)

Robert A Van Tassel (2 out of 65 patents)

4. Christopher H Porter (2 out of 39 patents)

5. Mark A Rydell (2 out of 78 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Illumenex Corporation. Retrieved from https://idiyas.com/company/illumenex

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]